Tositumomab is a drug for the treatment of follicular lymphoma.

Its use has been investigated, primarily in the treatment of follicular lymphoma.

Three groups of scientists decided to look at follicular lymphoma, the most common malignancy of blood cells.

In February 2010, Christensen announced that he had been diagnosed with follicular lymphoma.

"It tied in well with what we knew about follicular lymphoma; it kills people relatively slowly.

Of all cancers involving the same class of blood cell, 22% of cases are follicular lymphomas.

It is used to produce the BiovaxID vaccine for follicular lymphoma.

Pediatric follicular lymphoma is a disease that differs from the adult counterpart genetically and clinically.

The basic idea is to use plants as a factory to quickly and inexpensively grow vaccines tailored to each patient's follicular lymphoma.

However, there is a considerable increase in positive cells in follicular lymphoma, as well as many other forms of cancer.

In MeSH, it is currently classified under follicular lymphoma.

Some groups report a continuous relapse rate similar to the other follicular lymphomas (a pattern of indolent lymphoma).

They tested their strategy on 16 follicular lymphoma patients, growing their personalized vaccines in tobacco leaves for three to four months.

In 2010 it was approved by the European Commission for maintenance treatment after initial treatment of follicular lymphoma.

Phase III development in relapsed follicular lymphoma patients is underway.

Follicular lymphoma.

Follicular lymphoma is a common form of non-Hodgkin's lymphoma and accounts for about 15% of all cases.

One clinical trial (for refractory follicular lymphoma) was temporarily put on hold due to cardiac problems but resumed recruiting in 2009.

A Phase I clinical trial in follicular lymphoma was also conducted in Japan .

A centrocyte generally refers to a B cell with a cleaved nucleus, as may appear in e.g. follicular lymphoma.

Longo DL: What's the deal with follicular lymphomas?

Bcl-2 is a well known anti-apoptotic gene, and thus its overexpression results in the "failure to die" motif of cancer seen in follicular lymphoma.

I thought of a way of avoiding the cliché and asked, 'What is the average life expectancy of someone with follicular lymphoma?'

The study included 76 people with advanced follicular lymphoma (stage III and IV) who had not yet been treated for their disease.

As such, through its unique mode of action, and exemplary safety record, BiovaxID represents a new therapeutic approach to treating follicular lymphoma.